Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 19, 2014

Drug Name Review Type Class Manufacturer
Sovaldi New Drug Initial Review Hepatitis C Gilead
Otrexup New Drug Initial Review DMARD Antares
Brintellix New Drug Initial Review Antidepressant Takeda
Olysio New Drug Initial Review Hepatitis C Johnson & Johnson
Natroba New Drug Appeal Head Lice ParaPro
Quillivant XR New Drug Appeal Stimulant/ADHD Pfizer
Linzess New Drug Appeal Guanylate Cyclase-C Agonist Forest
TOBI Podhaler New Drug Appeal Aminoglycoside Novartis
Abilify Maintena PDL Appeal Atypical Antipsychotic Otsuka
Onglyza PDL Appeal DPP-4 Inhibitor AstraZeneca